Clinical Trial Update: Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease [NA]

View source ↗

Summary

The clinical trial NCT05962476 evaluating transcutaneous vibro-acoustic therapy for Parkinson's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinson Disease | NA | Status: TERMINATED